$0.67
+0.01 (+2.14%)
Open$0.65
Previous Close$0.65
Day High$0.67
Day Low$0.64
52W High$4.23
52W Low$0.53
Volume—
Avg Volume451.0K
Market Cap63.73M
P/E Ratio—
EPS$-5.54
SectorN/A
Analyst Ratings
Buy
10 analysts
Price Target
+489.5% upside
Current
$0.67
$0.67
Target
$3.93
$3.93
$2.76
$3.93 avg
$6.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.40B | 1.28B | 17.89M |
| Net Income | -556,458,347 | -457,613,772 | 2.66M |
| Profit Margin | -39.8% | -37.8% | 14.8% |
| EBITDA | -418,191,975 | -363,013,867 | 4.50M |
| Free Cash Flow | — | — | 2.54M |
| Rev Growth | +9.4% | +9.4% | -6.4% |
| Debt/Equity | 6.52 | 6.52 | 0.53 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $8.24 | +8.56% | — | 4.06B |
| PICS | Pics Nv | $11.15 | +6.65% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.97 | -0.10% | — | 656.41M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.18B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.56 | -0.14% | 63.3 | 608.01M |
| CEPF | Cantor Equity Partners-Cl A | $10.19 | -0.10% | 356.1 | 583.50M |